Emulating real-world GLP-1 efficacy in type 2 diabetes through causal learning and virtual patients.
Randomized controlled trials (RCTs) remain the benchmark for assessing treatment effects but are limited to phenotypically narrow populations by design. We introduce a novel generative artificial intelligence (AI) driven emulation method that infers effect size through virtual clinical trials, which...
Saved in:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2025-07-01
|
| Series: | PLOS Digital Health |
| Online Access: | https://doi.org/10.1371/journal.pdig.0000927 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|